VinaCapital Vietnam Opp Fund (LON:VOF - Get Free Report) shares reached a new 52-week high on Tuesday . The stock traded as high as GBX 494 ($6.68) and last traded at GBX 494 ($6.68), with a volume of 4743 shares traded. The stock had previously closed at GBX 489 ($6.61).
VinaCapital Vietnam Opp Fund Stock Down 0.6%
The firm's 50-day moving average price is GBX 452.59 and its 200-day moving average price is GBX 432.28. The company has a market cap of £867.09 million, a P/E ratio of 13.04 and a beta of 0.47.
Insiders Place Their Bets
In other VinaCapital Vietnam Opp Fund news, insider Charlotta Ginman bought 4,400 shares of the stock in a transaction on Monday, July 21st. The shares were acquired at an average price of GBX 456 per share, with a total value of £20,064. Corporate insiders own 0.06% of the company's stock.
About VinaCapital Vietnam Opp Fund
(
Get Free Report)
VinaCapital Vietnam Opportunity Fund Ltd (“the Company” or “VOF”) is a closed-end fund trading on the London Stock Exchange's Main Market.
Launched in 2003, VOF provides investors with access to the Vietnamese market across a range of industry sectors and asset classes, including but not limited to listed and unlisted equity*, private equity, operating assets and real estate projects.
Featured Articles
Before you consider VinaCapital Vietnam Opp Fund, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and VinaCapital Vietnam Opp Fund wasn't on the list.
While VinaCapital Vietnam Opp Fund currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.